Newsletter

Subscribe and receive updates on this company

Text STOCKS to 72727 for mobile alerts

We are excited to present Bank of Southern California, National Association (OTC: BCAL).

Full DD Report for BCAL

You must become a subscriber to view this report.


Recent News from (OTC: BCAL)

Bank of Southern California Announces First Quarter 2018 Results
SAN DIEGO , May 2, 2018 /PRNewswire/ -- Bank of Southern California , N.A. (OTC Pink: BCAL) announced quarterly earnings of $1,072,303 for the first quarter of 2018, a 51% increase compared to $710,022 for the first quarter of 2017. Results for the quarter ended March 31, 2018 , inc...
Source: PR Newswire
Date: May, 02 2018 06:00
Bank of Southern California Successfully Completes $26 Million Capital Offering
SAN DIEGO , April 2, 2018 /PRNewswire/ -- Bank of Southern California , N.A. (OTC Pink: BCAL) announced today the completion of a capital raise of approximately $26 million through the issuance of common stock in a private placement to institutional and accredited individual inves...
Source: PR Newswire
Date: April, 02 2018 06:00

 


About Bank of Southern California, National Association (OTC: BCAL)

Logo for Bank of Southern California, National Association (OTC: BCAL)

At Bank of Southern California, we are committed to serving the unique business, professional and personal banking needs of the vibrant Southern California communities we serve. We provide a full range of banking services deposit accounts, cash management tools and financing solutions all delivered with the exceptional, personalized service you d expect from your local bank.

 

Contact Information

 

 

Current Management

  • Nathan L. Rogge / CEO, President
    • Nathan brings his passion for building a great business bank to his leadership of Bank of Southern California. He began his career at Wells Fargo as Vice President and Senior Commercial Lending Officer, where he implemented successful sales and marketing strategies in the Sacramento and San Diego areas. He then moved to First National Bank of San Diego as Senior Vice President, Business Banking Group Manager. In , he joined First Republic Bank in San Francisco as their Senior Vice President and Head of Business Banking. He has been involved in LEAD San Diego, Banker s Small Business CDC, and RMA.
  • Anthony DiVita / EVP, Sales amp Mkt.
  • Pamela Isaacson / EVP, Admin. Officer
  • James Burgess / EVP, CFO
  • Robert Marshall / EVP, CCO
  • Margaret Rheinwald / Vice President, Controller

Current Share Structure

  • Market Cap: $77,832,042 - 03/14/2018
  • Authorized: 10,000,000 - 09/30/2017
  • Issue and Outstanding: 5,223,627 - 12/28/2017

 



Daily Technical Chart for (OTC: BCAL)

Daily Technical Chart for (OTC: BCAL)


Stay tuned for daily updates and more on (OTC: BCAL)

It most certainly could but even more important is the recent overwhelming interest in the company. Check out Investors Hub and search on Twitter

More to come on (OTC: BCAL)

Do your DD and if you choose, be ready to go!


 

The Research: All source information contained in this email is from the public sources mentioned below.

 

 
 

Thank you

OTC Report
@OTCReporter

 

 


Disclaimer: OTC Report publishes reports providing information on selected companies. OTC Report is not a registered investment advisor or broker-dealer. This report is provided as an information service only, and the statements and opinions in this report should not be construed as an offer or solicitation to buy or sell any security. OTC Report accepts no liability for any loss arising from an investors reliance on or use of this report. An investment in BCAL is considered to be highly speculative and should not be considered unless a person can afford a complete loss of investment. OTC Report has received up to $100,000 worth of crypto currency from a non-affiliated third party for the publication and circulation of this report. OTC Report does not own any shares of BCAL and does not buy, sell, or trade any shares of BCAL. This report contains forward-looking statements, which involve risks, and uncertainties that may cause actual results to differ materially from those set forth in the forward-looking statements. Copyright 2018 by OTC Report. All rights reserved. Our Full Disclaimer: http://otc.report/disclaimer/